Clinical Trial Details

NCT ID: NCT00753662
Date Last Changed: September 12, 2011


Research Study Summary

A Phase 2 clinical study for patients with Alzheimer's Disease

Research Study Title

Phase 2 (Feasibility) Study of Transcranial Magnetic Stimulation as Additional Therapy to Drug Treatment in Patients With Alzheimer's Disease


The primary objective of this trial is to assess the ability of Transcranial Magnetic Stimulation with H2 coil to prefrontal and parieto-temporal cortex to improve cognitive performance in patients with Alzheimer's disease which received drug treatment. This study is a single-center, double-blind 4 months duration trial.

To Learn more

Recruitment Details

Both Male and Female
50 to 80 Years
Overall Status
Lead Sponsor
Tel-Aviv Sourasky Medical Center
48 Months
Facility Type


Both Male and Female ages 50 Years to 80 Years

Inclusion Criteria:

  • Written informed consent will be obtained

  • diagnostic evidence of probable AD consistent with DSM IV

  • stable treatment with Acetylcholine-Esterase Inhibitors or/and Memantine for 5 weeks prior to screening

  • stable dose treatment with other drugs

  • MMSE < 25

Exclusion Criteria:

  • Patients with neurological or psychiatric disorders that affect cognition but are distinguishable from AD

  • Patients who are unwilling or unable to fulfill the requirements of the study

  • Severe personality disorder

  • Malignant or untreated Hypertension

  • History of Epilepsy

  • History of Head trauma

  • Metal implant in head, cardiac pacemaker, medical pump

  • Drug or alcohol addiction

  • Involvement in any other clinical trial during the preceding 3 month

  • Patient who are unwilling or unable to give Informed Consent

Site Locations (1)

Country State City Zip Facility and Contact
Israel Tel Aviv 64239 Tel Aviv Sourasky Medical Center, Neurology Department
Alissa Ash, Dr.


Alissa Ash, Dr.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.